← Leaderboards
James C Garbutt
University Of North Carolina Chapel Hill
$2,735,994
Attributed
$3,137,498
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $627.9K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,137,498 · 12
By mechanism
R21$1,548,529 · 4
R01$1,521,609 · 2
M01$67,360 · 6
Top collaborators
- Cort A Pedersen3 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- David H Overstreet$2,363,171
- A Leslie Morrow$10,230,852
- Cort A Pedersen$7,997,634
- Denise Dion Hallfors$10,295,163
- Linmarie Sikich$18,880,212
Others in their field
Top investigators on “Alcohol Dependence”
- Lloyd D Johnston · University Of Michigan At Ann Arbor$67,097,167
- Edward V Nunes · Columbia University Health Sciences$54,686,081
- Joel Gelernter · Washington University$48,859,217
- Marisa Roberto · Scripps Research Institute, The$33,529,580
- John P Rotrosen · New York University School Of Medicine$31,401,321
- Cindy L Ehlers · Scripps Research Institute, The$29,300,076
Research focus
Alcohol DependencePlacebosHeavy DrinkingPharmaceutical PreparationsRandomizedAlcoholsAlcohol CravingDouble-Blind Placebo Controlled TrialMedicalClinical TrialsNaltrexoneSeveritiesFda ApprovedSafetyDrinkingInnovationClinical CareDosePharmacotherapyBaclofenPlacebo ControlReportingEquilibriumBase
Grant awards (19)
Intranasal Oxytocin Treatment for Alcohol Use Disorders: A Randomized, Placebo-Controlled Trial$409,425
R01 · FY2018 · AA
Efficacy and Safety of the Melanocortin Activator Bupropion in Treating Binge Drinking$218,500
R21 · FY2018 · AA · contact PI
Efficacy and Safety of the Melanocortin Activator Bupropion in Treating Binge Drinking$180,500
R21 · FY2017 · AA · contact PI
Efficacy and Safety of High-Dose Baclofen for Alcohol Dependence$307,800
R01 · FY2016 · AA · contact PI
Efficacy and Safety of High-Dose Baclofen for Alcohol Dependence$265,392
R01 · FY2015 · AA · contact PI
Oxytocin Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial$175,084
R21 · FY2015 · AA
Efficacy and Safety of High-Dose Baclofen for Alcohol Dependence$265,392
R01 · FY2014 · AA · contact PI
Oxytocin Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial$218,500
R21 · FY2014 · AA
Efficacy and Safety of High-Dose Baclofen for Alcohol Dependence$273,600
R01 · FY2013 · AA · contact PI
Sweet Preference and Alcohol Craving Predict Naltrexone Response in Alcoholism$219,780
R21 · FY2010 · AA · contact PI
Sweet Preference and Alcohol Craving Predict Naltrexone Response in Alcoholism$185,000
R21 · FY2009 · AA · contact PI
CLINICAL TRIAL: EFFICACY AND SAFETY OF BACLOFEN FOR ALCOHOL DEPENDENCE$1,990
M01 · FY2008 · RR · contact PI
FEASIBILITY AND TOLERABILITY OF NALTREXONE AND BACLOFEN FOR ALCOHOL DEPENDENCE$1,301
M01 · FY2008 · RR · contact PI
EFFICACY AND SAFETY OF BACLOFEN FOR ALCOHOL DEPENDENCE$26,449
M01 · FY2007 · RR · contact PI
Efficacy and Safety of Baclofen for Alcohol Dependence$173,495
R21 · FY2006 · AA · contact PI
EFFICACY AND SAFETY OF BACLOFEN FOR ALCOHOL DEPENDENCE$20,567
M01 · FY2006 · RR · contact PI
NALTREXONE IN SWEET LIKERS VS NON-SWEET LIKERS WITH ALCOHOL DEPENDENCE$1,487
M01 · FY2006 · RR · contact PI
Efficacy and Safety of Baclofen for Alcohol Dependence$177,670
R21 · FY2005 · AA
Safety and Feasibility of Using Baclofen for Alcohol Dependence and Craving$15,566
M01 · FY2004 · RR